| Issue | No. | Table of contents |
|---|---|---|
| April 2026 | 428 | Full text [473 KB]
|
Menu
Close
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Post-marketing Safety Measures
- Provision of Information Regarding Post-marketing Safety
- Drugs
- MHLW Pharmaceuticals and Medical Devices Safety Information
- MHLW Pharmaceuticals and Medical Devices Safety Information (FY2026)
Post-marketing Safety Measures